Chronos Therapeutics

About Chronos Therapeutics

Proprietary positions in the regulation of cellular chronological lifespan allow Chronos Therapeutics’ research to be advanced into pre-clinical stages of development for age-related diseases quickly and efficiently.
YEAR FOUNDED:
2009
LEADERSHIP:
CEO: Huw Jones, PhD
Chairman: Christian Hoyer Millar, MA
CLINICAL TRIAL:
Please click here for clinical trial information.